# Verano Holdings Corp.: financial statements, quarterly

VRNO · OTC · CIK 1848416 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrno.md) · [Financials](/companies/vrno/financials.md) · [Filings](/companies/vrno/filings.md) · [Insiders](/companies/vrno/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vrno/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [237 d](/filings/0001628280-26-017011.md) | [221](/filings/0001628280-25-023443.md) | [222](/filings/0001628280-25-038589.md) | [217](/filings/0001628280-25-046911.md) | [218 d](/filings/0001628280-26-017011.md) | [210](/filings/0001628280-26-028574.md) | [202](/filings/0001628280-26-052919.md) | [203](/filings/0001848416-26-000005.md) | [207 d](/filings/0001628280-26-017011.md) | [208](/filings/0001628280-26-028574.md) | [218](/filings/0001628280-26-052919.md) | [212](/filings/0001848416-26-000005.md) |
| Cost of revenue | $m | [120 d](/filings/0001628280-26-017011.md) | [108](/filings/0001628280-25-023443.md) | [108](/filings/0001628280-25-038589.md) | [108](/filings/0001628280-25-046911.md) | [111 d](/filings/0001628280-26-017011.md) | [110](/filings/0001628280-26-028574.md) | [89.3](/filings/0001628280-26-052919.md) | [108](/filings/0001848416-26-000005.md) | [101 d](/filings/0001628280-26-017011.md) | [109](/filings/0001628280-26-028574.md) | [118](/filings/0001628280-26-052919.md) | [112](/filings/0001848416-26-000005.md) |
| Gross profit | $m | [118 d](/filings/0001628280-26-017011.md) | [113](/filings/0001628280-25-023443.md) | [114](/filings/0001628280-25-038589.md) | [109](/filings/0001628280-25-046911.md) | [108 d](/filings/0001628280-26-017011.md) | [99.6](/filings/0001628280-26-028574.md) | [113](/filings/0001628280-26-052919.md) | [95.2](/filings/0001848416-26-000005.md) | [106 d](/filings/0001628280-26-017011.md) | [99.0](/filings/0001628280-26-028574.md) | [99.7](/filings/0001628280-26-052919.md) | [100](/filings/0001848416-26-000005.md) |
| Selling, general and administrative | $m | [85.7 d](/filings/0001628280-26-017011.md) | [90.3](/filings/0001628280-25-023443.md) | [87.1](/filings/0001628280-25-038589.md) | [92.3](/filings/0001628280-25-046911.md) | [83.7 d](/filings/0001628280-26-017011.md) | [84.6](/filings/0001628280-26-028574.md) | [86.3](/filings/0001628280-26-052919.md) | [80.6](/filings/0001848416-26-000005.md) | [85.8 d](/filings/0001628280-26-017011.md) | [85.9](/filings/0001628280-26-028574.md) | [92.5](/filings/0001628280-26-052919.md) | [84.5](/filings/0001848416-26-000005.md) |
| Operating income | $m | [(19.7) d](/filings/0001628280-26-017011.md) | [22.7](/filings/0001628280-25-023443.md) | [27.3](/filings/0001628280-25-038589.md) | [16.8](/filings/0001628280-25-046911.md) | [(304) d](/filings/0001628280-26-017011.md) | [15.0](/filings/0001628280-26-028574.md) | [26.2](/filings/0001628280-26-052919.md) | [9.3](/filings/0001848416-26-000005.md) | [(158) d](/filings/0001628280-26-017011.md) | [13.1](/filings/0001628280-26-028574.md) | [3.1](/filings/0001628280-26-052919.md) | [11.9](/filings/0001848416-26-000005.md) |
| Income tax | $m | [44.4 d](/filings/0001628280-26-017011.md) | [11.5](/filings/0001628280-25-023443.md) | [30.5](/filings/0001628280-25-038589.md) | [45.5](/filings/0001628280-25-046911.md) | [(45.5) d](/filings/0001628280-26-017011.md) | [17.3](/filings/0001628280-26-028574.md) | [35.2](/filings/0001628280-26-052919.md) | [28.4](/filings/0001848416-26-000005.md) | [10.7 d](/filings/0001628280-26-017011.md) | [11.6](/filings/0001628280-26-028574.md) | [2.9](/filings/0001628280-26-052919.md) | [7.3](/filings/0001848416-26-000005.md) |
| Net income | $m | [(77.2) d](/filings/0001628280-26-017011.md) | [(4.8)](/filings/0001628280-25-023443.md) | [(21.8)](/filings/0001628280-25-038589.md) | [(42.6)](/filings/0001628280-25-046911.md) | [(273) d](/filings/0001628280-26-017011.md) | [(11.5)](/filings/0001628280-26-028574.md) | [(19.2)](/filings/0001628280-26-052919.md) | [(43.8)](/filings/0001848416-26-000005.md) | [(183) d](/filings/0001628280-26-017011.md) | [(17.8)](/filings/0001628280-26-028574.md) | [(13.4)](/filings/0001628280-26-052919.md) | [(4.1)](/filings/0001848416-26-000005.md) |
| Diluted EPS | $ per share | not reported | [(0.01)](/filings/0001628280-25-023443.md) | [(0.06)](/filings/0001628280-25-038589.md) | [(0.12)](/filings/0001628280-25-046911.md) | not reported | [(0.03)](/filings/0001628280-26-028574.md) | [(0.27)](/filings/0001628280-26-052919.md) | [(0.61)](/filings/0001848416-26-000005.md) | not reported | [(0.05)](/filings/0001628280-26-028574.md) | [(0.18)](/filings/0001628280-26-052919.md) | [(0.06)](/filings/0001848416-26-000005.md) |
| Basic EPS | $ per share | not reported | [(0.01)](/filings/0001628280-25-023443.md) | [(0.06)](/filings/0001628280-25-038589.md) | [(0.12)](/filings/0001628280-25-046911.md) | not reported | [(0.03)](/filings/0001628280-26-028574.md) | [(0.27)](/filings/0001628280-26-052919.md) | [(0.61)](/filings/0001848416-26-000005.md) | not reported | [(0.05)](/filings/0001628280-26-028574.md) | [(0.18)](/filings/0001628280-26-052919.md) | [(0.06)](/filings/0001848416-26-000005.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [175](/filings/0001628280-25-008390.md) | [194](/filings/0001628280-24-021332.md) | [130](/filings/0001628280-24-035351.md) | [65.0](/filings/0001628280-24-045933.md) | [87.8](/filings/0001628280-26-017011.md) | [84.2](/filings/0001628280-25-023443.md) | [68.6](/filings/0001628280-25-038589.md) | [82.6](/filings/0001628280-25-046911.md) | [82.7](/filings/0001848416-26-000005.md) | [74.0](/filings/0001628280-26-028574.md) | [85.2](/filings/0001628280-26-052919.md) | [102](/filings/0001848416-26-000005.md) |
| Current assets | $m | [394](/filings/0001628280-25-008390.md) | [419](/filings/0001628280-24-021332.md) | [358](/filings/0001628280-24-035351.md) | [322](/filings/0001628280-24-045933.md) | [363](/filings/0001628280-26-017011.md) | [361](/filings/0001628280-25-023443.md) | [371](/filings/0001628280-25-038589.md) | [385](/filings/0001628280-25-046911.md) | [405](/filings/0001848416-26-000005.md) | [395](/filings/0001628280-26-028574.md) | [404](/filings/0001628280-26-052919.md) | [416](/filings/0001848416-26-000005.md) |
| Total assets | $m | [2,319](/filings/0001628280-25-008390.md) | [2,315](/filings/0001628280-24-021332.md) | [2,239](/filings/0001628280-24-035351.md) | [2,315](/filings/0001628280-24-045933.md) | [1,994](/filings/0001628280-26-017011.md) | [1,969](/filings/0001628280-25-023443.md) | [1,942](/filings/0001628280-25-038589.md) | [1,925](/filings/0001628280-25-046911.md) | [1,742](/filings/0001848416-26-000005.md) | [1,708](/filings/0001628280-26-028574.md) | [1,699](/filings/0001628280-26-052919.md) | [1,707](/filings/0001848416-26-000005.md) |
| Current liabilities | $m | [412](/filings/0001628280-25-008390.md) | [415](/filings/0001628280-24-021332.md) | [361](/filings/0001628280-24-035351.md) | [435](/filings/0001628280-24-045933.md) | [203](/filings/0001628280-26-017011.md) | [168](/filings/0001628280-25-023443.md) | [148](/filings/0001628280-25-038589.md) | [143](/filings/0001628280-25-046911.md) | [140](/filings/0001848416-26-000005.md) | [119](/filings/0001628280-26-028574.md) | [109](/filings/0001628280-26-052919.md) | [114](/filings/0001848416-26-000005.md) |
| Total liabilities | $m | [1,079](/filings/0001628280-25-008390.md) | [1,076](/filings/0001628280-24-021332.md) | [1,018](/filings/0001628280-24-035351.md) | [1,097](/filings/0001628280-24-045933.md) | [1,043](/filings/0001628280-26-017011.md) | [1,027](/filings/0001628280-25-023443.md) | [1,016](/filings/0001628280-25-038589.md) | [1,041](/filings/0001628280-25-046911.md) | [1,039](/filings/0001848416-26-000005.md) | [1,022](/filings/0001628280-26-028574.md) | [1,025](/filings/0001628280-26-052919.md) | [1,037](/filings/0001848416-26-000005.md) |
| Long-term debt | $m | [394](/filings/0001628280-25-008390.md) | [391](/filings/0001628280-24-021332.md) | [392](/filings/0001628280-24-035351.md) | [398](/filings/0001628280-24-045933.md) | [396](/filings/0001628280-26-017011.md) | [404](/filings/0001628280-25-023443.md) | [400](/filings/0001628280-25-038589.md) | [398](/filings/0001628280-25-046911.md) | [392](/filings/0001848416-26-000005.md) | [384](/filings/0001628280-26-028574.md) | [382](/filings/0001628280-26-052919.md) | [380](/filings/0001848416-26-000005.md) |
| Current portion of debt | $m | [52.0](/filings/0001628280-25-008390.md) | [53.4](/filings/0001628280-24-021332.md) | [4.1](/filings/0001628280-24-035351.md) | [22.5](/filings/0001628280-24-045933.md) | [18.2](/filings/0001628280-26-017011.md) | [16.8](/filings/0001628280-25-023443.md) | [3.4](/filings/0001628280-25-038589.md) | [2.9](/filings/0001628280-25-046911.md) | [7.9](/filings/0001848416-26-000005.md) | [10.7](/filings/0001628280-26-028574.md) | [10.5](/filings/0001628280-26-052919.md) | [10.4](/filings/0001848416-26-000005.md) |
| Shareholders' equity | $m | [1,240](/filings/0001628280-25-008390.md) | [1,239](/filings/0001628280-24-035351.md) | [1,221](/filings/0001628280-24-035351.md) | [1,218](/filings/0001628280-24-045933.md) | [952](/filings/0001628280-26-017011.md) | [943](/filings/0001628280-25-023443.md) | [927](/filings/0001628280-25-038589.md) | [886](/filings/0001628280-25-046911.md) | [704](/filings/0001848416-26-000005.md) | [688](/filings/0001628280-26-028574.md) | [677](/filings/0001628280-26-052919.md) | [672](/filings/0001848416-26-000005.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.3 d](/filings/0001628280-26-017011.md) | [31.0](/filings/0001628280-25-023443.md) | [7.9 d](/filings/0001628280-25-038589.md) | [29.7 d](/filings/0001628280-25-046911.md) | [43.5 d](/filings/0001628280-26-017011.md) | [1.8](/filings/0001628280-26-028574.md) | [10.9 d](/filings/0001628280-26-052919.md) | [26.4 d](/filings/0001848416-26-000005.md) | [13.8 d](/filings/0001628280-26-017011.md) | [18.6](/filings/0001628280-26-028574.md) | [30.6 d](/filings/0001628280-26-052919.md) | [48.7 d](/filings/0001848416-26-000005.md) |
| Capital expenditure | $m | [9.8 d](/filings/0001628280-26-017011.md) | [9.7](/filings/0001628280-25-023443.md) | [18.5 d](/filings/0001628280-25-038589.md) | [56.6 d](/filings/0001628280-25-046911.md) | [14.2 d](/filings/0001628280-26-017011.md) | [13.9](/filings/0001628280-26-028574.md) | [10.5 d](/filings/0001628280-26-052919.md) | [7.5 d](/filings/0001848416-26-000005.md) | [9.4 d](/filings/0001628280-26-017011.md) | [14.9](/filings/0001628280-26-028574.md) | [11.9 d](/filings/0001628280-26-052919.md) | [13.1 d](/filings/0001848416-26-000005.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001848416-26-000005.md) | not reported | not reported | not reported | [1.7 d](/filings/0001848416-26-000005.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [341](/filings/0001628280-24-021332.md) | [343](/filings/0001628280-24-035351.md) | [343](/filings/0001628280-24-045933.md) | [344](/filings/0001628280-25-023443.md) | [345](/filings/0001628280-25-038589.md) | [351](/filings/0001628280-25-046911.md) | [359](/filings/0001628280-26-028574.md) | [72.1](/filings/0001628280-26-052919.md) | [72.4](/filings/0001848416-26-000005.md) | [363](/filings/0001628280-26-028574.md) | [73.0](/filings/0001628280-26-052919.md) | [73.1](/filings/0001848416-26-000005.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 72,934,412 at 2026-10-27, from the cover of the [10-Q filed 2026-10-29](/filings/0001848416-26-000005.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:05 ET. No prices; not investment advice.